NCT05205876View on ClinicalTrials.gov

Safety and Feasibility Study of the Eddii Mobile Application

NACompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

January 2, 2021

Primary Completion Date

July 31, 2022

Study Completion Date

August 31, 2022

Conditions
Type-1 Diabetes
Interventions
BEHAVIORAL

Eddii mobile application

Participants will use the Eddii mobile application in the intervention arm.

Trial Locations (1)

10016

Eddii, inc., New York

All Listed Sponsors
lead

Eddii, Inc.

INDUSTRY

NCT05205876 - Safety and Feasibility Study of the Eddii Mobile Application | Biotech Hunter | Biotech Hunter